Proton pump inhibitors for prevention of upper and lower gastrointestinal bleeding in patients taking aspirin: a systematic review and meta-analysis
European Journal of Clinical Pharmacology · 2026-08 · 82 (8)
DOI: 10.1007/s00228-026-04135-2 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 21.07.2026. Verfasst von Siqi Jia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of the Shenyang Pharmaceutical University), No. 83 We…. Hauptthemen laut MEDLINE: Gastrointestinal Hemorrhage, Proton Pump Inhibitors, Aspirin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Independent Research Funding of the General Hospital of Northern Theater Command, Liaoning Revitalization Talents Program.
Abstract (Originalsprache)
OBJECTIVES: Proton pump inhibitors (PPIs) are recommended for the prevention of aspirin-associated gastrointestinal mucosal injury, but emerging evidence indicates that PPIs may increase the risk of lower gastrointestinal bleeding (LGIB). This meta-analysis aimed to comprehensively evaluate the effects of PPIs on gastrointestinal bleeding (GIB). METHODS: Major electronic databases were searched to identify the studies evaluating the differences between PPIs versus placebo/blank, no-PPI, histamine-2 receptor antagonists (H2RAs), mucosal protective agents (MPAs), and potassium-competitive acid blockers (P-CABs) in preventing aspirin-associated GIB. Risk ratios (RRs) with their 95% confidence intervals (CIs) were calculated. RESULTS: Sixteen randomized controlled trials (RCTs) and 14 non-RCTs were included. PPIs group had significantly lower risk of upper gastrointestinal bleeding (UGIB) than placebo/blank group (7 RCTs, RR = 0.30, 95%CI = 0.19-0.46; 2 non-RCTs, RR = 0.05, 95%CI = 0.01-0.42), no-PPI group (7 non-RCTs, RR = 0.50, 95%CI = 0.38-0.66), H2RAs group (5 RCTs, RR = 0.21, 95%CI = 0.09-0.53; 4 non-RCTs, RR = 0.12, 95%CI = 0.03-0.52), and MPAs group (4 RCTs, RR = 0.24, 95%CI = 0.10-0.58), but statistically similar (2 non-RCTs, RR = 1.18, 95%CI = 0.77-1.79) or significantly higher (1 RCT, log-rank P = 0.018 and 0.019) risk of UGIB than P-CABs group. PPIs group had significantly higher risk of lower gastrointestinal bleeding (LGIB) than no-PPI group (3 non-RCTs, RR = 2.85, 95%CI = 1.85-4.38), but statistically similar risk of LGIB to H2RAs group (2 RCTs, RR = 1.88, 95%CI = 0.30-11.82). CONCLUSIONS: The evidence from RCTs and non-RCTs suggests the advantages of PPIs over placebo/blank, no-PPI, H2RAs, and MPAs for the prevention of UGIB in aspirin users. The evidence regarding PPIs and LGIB in aspirin users is from non-RCTs alone, and suggests their potential harms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of the Shenyang Pharmaceutical University), No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China.
- Postgraduate College, Shenyang Pharmaceutical University, Shenyang, China.
- General Hospital of Northern Theater Command, China Medical University, Shenyang, China.
- Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of the Shenyang Pharmaceutical University), No. 83 Wenhua Road, Shenyang, 110840, Liaoning Province, China. xingshunqi@126.…
- Postgraduate College, Shenyang Pharmaceutical University, Shenyang, China. xingshunqi@126.com.
- General Hospital of Northern Theater Command, China Medical University, Shenyang, China. xingshunqi@126.com.
ORCID-Profile: Xingshun Qi
Förderung
- Independent Research Funding of the General Hospital of Northern Theater Command
- Liaoning Revitalization Talents Program
Zitieren
APA
Jia, S., Yin, Y., Huo, W., Lu, H., Gao, Y., & Qi, X. (2026). Proton pump inhibitors for prevention of upper and lower gastrointestinal bleeding in patients taking aspirin: a systematic review and meta-analysis. European Journal of Clinical Pharmacology, 82(8). https://doi.org/10.1007/s00228-026-04135-2
Vancouver
Jia S, Yin Y, Huo W, Lu H, Gao Y, Qi X. Proton pump inhibitors for prevention of upper and lower gastrointestinal bleeding in patients taking aspirin: a systematic review and meta-analysis. European Journal of Clinical Pharmacology. 2026;82(8). doi:10.1007/s00228-026-04135-2
BibTeX
@article{Jia2026,
author = {Jia, Siqi and Yin, Yuhang and Huo, Wenhui and Lu, Huiyuan and Gao, Yanhong and Qi, Xingshun},
title = {Proton pump inhibitors for prevention of upper and lower gastrointestinal bleeding in patients taking aspirin: a systematic review and meta-analysis},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {8},
doi = {10.1007/s00228-026-04135-2}
}
EUVIMED